Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ID2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
DERA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FECH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALCOCO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNTB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VWA5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADCY7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM7SF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RMDN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C19orf54 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM127 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LITAF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TECPR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on